drugset / Trial / NCT04188158

Analysis of the Effectiveness of Neoadjuvant Chemotherapy in the Treatment of Colon Cancer Locally Advanced (ELECLA)

NCT04188158 ↗

Phase 2 Unknown 238 enrolled Universidad de León
RandomizedParallel-groupOpen-labelTreatment

Summary

Effectiveness analysis of neoadjuvant chemotherapy in the treatment of locally advanced colon cancer. ELECLA trial

Timeline

Start
2017-03-10
Primary completion
2023-05-10
Completion
2024-03-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule — —
Subject Oxaliplatin Small molecule — —

Indications